Case report: Ipilimumab and nivolumab in metastatic adrenocortical cancer with high tumor mutational burden.
Frontiers in oncology
View this publicationFrontiers in oncology
View this publicationFrontiers in immunology
View this publicationAnnals of hematology
View this publicationFrontiers in immunology
View this publicationInfection
View this publicationFrontiers in immunology
View this publicationCancers
View this publicationJournal of cancer research and clinical oncology
View this publicationJournal of cancer research and clinical oncology
View this publicationFrontiers in immunology
View this publication